Michael Sinclair
Director, 10% owner at Opiant Pharmaceuticals, Inc. (OPNT)
Michael Sinclair has filed 6 insider reports with the SEC since August 2021, as director and 10% owner at Opiant Pharmaceuticals, Inc. (OPNT). Michael Sinclair made no open-market purchases or sales in the last 12 months. The latest filing, on March 3, 2023, reports sale back to the company at Opiant Pharmaceuticals, Inc. (OPNT).
- Filings
- 6
- Companies
- 1
- Bought on market
- None
- Sold on market
- $2.99M
Companies where Michael Sinclair is an insider
| Company | Role | Shares held | Bought | Sold | Last filing |
|---|---|---|---|---|---|
| OPNT Opiant Pharmaceuticals, Inc. | Director, 10% owner | 0 | $2.99M | Mar 3, 2023 |
Shares held: common shares owned directly after the latest filing that states it.
Every filing
- Mar 2, 2023OPNTSEC Form 4: Sinclair Michael returned $1,803,400 worth of shares to the company (90,170 units at $20.00), closing all direct ownership in the companyForm 4Sale back to the company
- Jun 15, 2022-$149KOPNTSEC Form 4: Sinclair Michael sold $149,188 worth of shares (13,616 units at $10.96), decreasing direct ownership by 41% to 19,220 unitsForm 4Open-market sale
- Jun 9, 2022-$96.7KOPNTSEC Form 4: Sinclair Michael sold $96,726 worth of shares (7,896 units at $12.25), decreasing direct ownership by 19% to 32,836 unitsForm 4Open-market sale
- Jun 7, 2022-$110KOPNTSEC Form 4: Sinclair Michael sold $109,771 worth of shares (8,488 units at $12.93), decreasing direct ownership by 17% to 40,732 unitsForm 4Open-market sale
- Jun 3, 2022-$275KOPNTSEC Form 4: Sinclair Michael sold $274,623 worth of shares (20,000 units at $13.73), decreasing direct ownership by 29% to 49,220 unitsForm 4Open-market sale
- Aug 25, 2021-$2.36MOPNTSEC Form 4: Sinclair Michael exercised 150,000 units of Common Stock at a strike of $5.00 and sold $2,356,674 worth of Common Stock (150,000 units at $15.71)Form 4Exercise or conversion of a derivativeOpen-market sale
Questions about Michael Sinclair
- What is Michael Sinclair's role at Opiant Pharmaceuticals, Inc.?
- Michael Sinclair reports to the SEC as director and 10% owner at Opiant Pharmaceuticals, Inc. (OPNT), according to the latest filing on March 3, 2023.
- Has Michael Sinclair bought or sold stock recently?
- The most recent open-market sale was on June 15, 2022: sold 13,616 shares of Opiant Pharmaceuticals, Inc. (OPNT) for $149K at an average of $10.96.
- How do I get alerts when Michael Sinclair files?
- Follow Michael Sinclair on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5.
From SEC Forms 4 and 5 filed by Michael Sinclair (SEC CIK 0001551246). Totals count each trade once, skipping amendments whose original is on file, from Aug 25, 2021 on. View on SEC EDGAR